Listed

ProPhase Labs, Inc.: Form 10-K for the period ended Dec 31, 2014

Filed with the SEC on Mar 27, 2015 and accepted by EDGAR at Mar 27, 2015, 17:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-10-01 to 2014-12-31$9.0mus-gaap:SalesRevenueNet
Revenue12 months2014-01-01 to 2014-12-31$22.1mus-gaap:SalesRevenueNet
Cost of revenue12 months2014-01-01 to 2014-12-31$7.9mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2014-10-01 to 2014-12-31$5.9mus-gaap:GrossProfit
Gross profit12 months2014-01-01 to 2014-12-31$14.2mus-gaap:GrossProfit
Research and development12 months2014-01-01 to 2014-12-31$1.3mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2014-01-01 to 2014-12-31−$7.8mus-gaap:OperatingIncomeLoss
Interest expense12 months2014-01-01 to 2014-12-31$10.0kus-gaap:InterestExpense
Income tax12 months2014-01-01 to 2014-12-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-10-01 to 2014-12-31−$676.0kus-gaap:NetIncomeLoss
Net income12 months2014-01-01 to 2014-12-31−$7.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-10-01 to 2014-12-31−$0.05us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2014-01-01 to 2014-12-31−$0.47us-gaap:EarningsPerShareDiluted
Basic EPS12 months2014-01-01 to 2014-12-31−$0.47us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2014-01-01 to 2014-12-3116,773,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure12 months2014-01-01 to 2014-12-31$312.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-12-31$2.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-12-31$13.5mus-gaap:AssetsCurrent
Total assetsAt period end2014-12-31$16.1mus-gaap:Assets
Current liabilitiesAt period end2014-12-31$5.2mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-12-31$10.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-15-018860. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.